↓ Skip to main content

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Overview of attention for article published in Cardiovascular Diabetology, January 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
30 X users
facebook
2 Facebook pages

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
149 Mendeley